PFBT
URGN icon

Parkside Financial Bank & Trust’s UroGen Pharma URGN Stock Holding History

Parkside Financial Bank & Trust’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$810 Hold
45
– – ﹤0.01% 2425
2025
Q4 		$1.05K Hold
45
– – ﹤0.01% 2334
2025
Q3 		$898 Hold
45
– – ﹤0.01% 2326
2025
Q2 		$617 Buy
+45
New +$432 ﹤0.01% 2429

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Parkside Financial Bank & Trust's URGN Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its UroGen Pharma (URGN) position steady in Q1 2026 at 45 shares worth $810. The position accounts for ﹤0.01% of the portfolio, ranked #2425.

Parkside Financial Bank & Trust first reported a position in URGN in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.05K in Q4 2025. 173 funds tracked by Wall St. Rank hold URGN as of Q1 2026.

  • Parkside Financial Bank & Trust held 45 shares of UroGen Pharma worth $810 as of Q1 2026.
  • Parkside Financial Bank & Trust left its UroGen Pharma share count unchanged in Q1 2026.
  • UroGen Pharma made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2425 holding.
  • Parkside Financial Bank & Trust first reported a position in UroGen Pharma in Q2 2025 and has held it in 4 quarters since.
  • Parkside Financial Bank & Trust's UroGen Pharma position peaked at $1.05K in Q4 2025.
  • 173 funds tracked by Wall St. Rank held UroGen Pharma as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.